Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a minor UI/version update to the page rendering. It does not modify the study data or how the page operates.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page, reflecting a minor version update to the site's rendering or functionality. This update does not alter study details or other visible content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note; it also reflects a header labeling change for Intervention/Treatment and a version update to Revision: v3.6.0.SummaryDifference0.3%

- Check45 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor update to the page metadata.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision tag on the page was updated from v3.5.3 to v3.5.4, indicating a newer build/version of the page. No changes to the study information are indicated.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page’s revision/build label was incremented from v3.5.2 to v3.5.3, indicating an implementation update without changing the displayed study details.SummaryDifference0.0%

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.